Perry B D, Simon P R, U'Prichard D C
Eur J Pharmacol. 1983 Nov 25;95(3-4):315-8. doi: 10.1016/0014-2999(83)90654-4.
Several recent studies have suggested a connection between neuroleptics and/or dopamine systems, and alpha 2-adrenergic receptors. Competition of a variety of neuroleptics at specific alpha 2-adrenergic binding sites (labeled with [3H]rauwolscine or [3H]p-aminoclonidine) in bovine caudate and cortex was examined. Few of the compounds were potent competitors, with (+)-butaclamol, alpha-flupenthixol, clozapine and pimozide the most potent (IC50 range 100-600 nM), while triflupromazine, mesoridazine, and haloperidol were the least potent (IC50 range 5 000-10 000 nM). These findings indicate that few, if any, of the examined neuroleptics have specific, high-affinity interactions with the multiple affinity states of the alpha 2-adrenergic receptor.
最近的几项研究表明,抗精神病药物和/或多巴胺系统与α2-肾上腺素能受体之间存在联系。研究了多种抗精神病药物在牛尾状核和皮质中特定α2-肾上腺素能结合位点(用[3H]萝芙辛或[3H]对氨基可乐定标记)的竞争情况。很少有化合物是强效竞争者,其中(+)-布他拉莫、α-氟奋乃静、氯氮平和匹莫齐特最为强效(IC50范围为100-600 nM),而三氟拉嗪、美索达嗪和氟哌啶醇最不强效(IC50范围为5000-10000 nM)。这些发现表明,在所研究的抗精神病药物中,很少有(如果有的话)与α2-肾上腺素能受体的多种亲和力状态具有特异性、高亲和力的相互作用。